Concord Medical Services (NYSE:CCM) Releases Earnings Results

Concord Medical Services (NYSE:CCM) released its earnings results on Wednesday. The company reported ($1.08) EPS for the quarter, FiscalAI reports.

Concord Medical Services Trading Up 0.3%

Shares of NYSE CCM traded up $0.01 during trading on Friday, reaching $3.96. The company had a trading volume of 1,912 shares, compared to its average volume of 4,976. Concord Medical Services has a 12-month low of $3.18 and a 12-month high of $10.77. The business’s 50-day moving average is $3.76 and its 200 day moving average is $4.22.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Concord Medical Services currently has a consensus rating of “Sell”.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.